Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
NCT ID: NCT00160160
Last Updated: 2009-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
440 participants
INTERVENTIONAL
2004-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
eprosartan/HCTZ
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diabetes type 2
Exclusion Criteria
* grade 3 hypertension,
* secondary hypertension,
* abnormal liver enzymes
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Solvay Pharmaceuticals
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Global Clinical Director Solvay
Role: STUDY_DIRECTOR
Solvay Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site 26
Calgary, , Canada
Site 27
Montreal, , Canada
Site 30
Québec, , Canada
Site 31
Thornhill, , Canada
Site 28
Vancouver, , Canada
Site 29
Winnipeg, , Canada
Site 39
Holbæk, , Denmark
Site 38
Roskilde, , Denmark
Site 40
Viborg, , Denmark
Site 4
Anzin, , France
Site 3
Blois, , France
Site 10
Chemellier, , France
Site 11
Cholet, , France
Site 15
Cholet, , France
Site 16
Cholet, , France
Site 14
La Jubaudière, , France
Site 13
Le Mesnil-en-Vallée, , France
Site 7
Mûrs-Erigné, , France
Site 12
Saint Pierre Montlim, , France
Site 9
Saumur, , France
Site 8
Segré, , France
Site 6
Thouars, , France
Site 2
Tours, , France
Site 5
Vieux-Condé, , France
Site 20
Bad Muenster, , Germany
Site 22
Flörsheim, , Germany
Site 19
Kirweiler, , Germany
Site 21
Lambrecht, , Germany
Site 25
Lindau, , Germany
Site 24
Lutherstadt, , Germany
Site 18
Lüneburg, , Germany
Site 17
Riesa, , Germany
Site 23
Waldbrunn, , Germany
Site 62
Bologna, , Italy
Site 60
Napoli, , Italy
Site 58
Padua, , Italy
Site 59
Palermo, , Italy
Site 63
Pavia, , Italy
Site 61
Pisa, , Italy
Site 64
Torino, , Italy
Site 43
Ålesund, , Norway
Site 42
Bergen, , Norway
Site 44
Horten, , Norway
Site 41
Skedsmokorset, , Norway
Site 55
Badajoz, , Spain
Site 51
Badalona, , Spain
Site 56
Barcelona, , Spain
Site 57
Barcelona, , Spain
Site 54
Ciudad Real, , Spain
Site 53
Granada, , Spain
Site 52
Madrid, , Spain
Site 48
Ängelholm, , Sweden
Site 47
Gothenburg, , Sweden
Site 46
Helsingborg, , Sweden
Site 45
Kristianstat, , Sweden
Site 50
Malmo, , Sweden
Site 49
Stockholm, , Sweden
Site 33
Aberdeen, , United Kingdom
Site 36
Bath, , United Kingdom
Site 37
Liverpool, , United Kingdom
Site 34
Manchester, , United Kingdom
Site 32
Oldham, , United Kingdom
Site 35
Rugby, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2004-00703-18
Identifier Type: -
Identifier Source: secondary_id
S171.3.012
Identifier Type: -
Identifier Source: org_study_id